Pacific Oil Co. (POIL) Financials Nov 14, 2014, 8:10

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Pacific Oil Co. (POIL) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Pacific Oil Co.


Fiscal year is October-September. All values USD millions. 2009 2010 2011 2012 5-year trend
Sales/Revenue - 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 0 0 0 0
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense - 0 0 0 0
Depreciation - 0 0 0 0
Amortization of Intangibles - 0 0 0 0
Gross Income - 0 0 0 0
2009 2010 2011 2012 5-year trend
SG&A Expense - 208 19,978 45,591 33,558
Research & Development - 0 0 0 0
Other SG&A - 208 19,978 45,591 33,558
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 0 0
EBIT after Unusual Expense - 0 0 0 0
Non Operating Income/Expense - (1,374) 0 16,410 5,999
Non-Operating Interest Income - - - - 0
Equity in Affiliates (Pretax) - 0 0 0 -
Interest Expense - 0 1,551 4,666 6,894
Gross Interest Expense - 0 1,551 4,666 6,894
Interest Capitalized - 0 0 0 0
Pretax Income - (1,582) (21,529) (33,847) (34,453)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 0 -
Income Tax - Current Foreign - 0 0 0 -
Income Tax - Deferred Domestic - 0 0 0 -
Income Tax - Deferred Foreign - 0 0 0 -
Income Tax Credits - 0 0 0 -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - (1,582) (21,529) (33,847) (34,453)
Minority Interest Expense - 0 0 0 0
Net Income - (1,582) (21,529) (33,847) (34,453)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (1,582) (21,529) (33,847) (34,453)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (1,582) (21,529) (33,847) (34,453)
EPS (Basic) - () () (1.00) (1.00)
Basic Shares Outstanding - 57,490 57,490 57,490 57,490
EPS (Diluted) - () () (1.00) (1.00)
Diluted Shares Outstanding - 57,490 57,490 57,490 57,490
EBITDA - (208) (19,978) (45,591) (33,558)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Solis Agrosciences Gains Series A Funding to Drive Growth Forward

Updated Category News Views 272

Solis Agrosciences Gains Series A Funding to Drive Growth Forward Solis Agrosciences, a prominent name in the Agtech sector, has announced a significant milestone in its journey of innovation and growth. The company has successfully secured Series A funding from Cultivation Capital, an investment that promises to amplify its business operations and expand its array of...

Continue Reading
Blink Charging: Milestone Achievements and Future Outlook

Updated Category News Views 283

Update on Blink Charging and Its Stock Performance Blink Charging Co. (NASDAQ: BLNK) shares saw an upward trend recently, as the company proudly announced it surpassed 100,000 electric vehicle (EV) chargers sold, deployed, or contracted globally. This significant accomplishment highlights Blink's growth in the EV infrastructure sector. The company's success can be...

Continue Reading
Vanguard Unveils Innovative Active Equity ETF Range

Updated Category News Views 228

Vanguard Launches New Active Equity ETFs Vanguard has recently introduced three active equity ETFs aimed at enhancing investor portfolio options. The newly launched funds are the Vanguard Wellington U.S. Value Active ETF (VUSV), Vanguard Wellington U.S. Growth Active ETF (VUSG), and Vanguard Wellington Dividend Growth Active ETF (VDIG), each managed by the esteemed...

Continue Reading
New COVID-19 Vaccine by Pfizer and BioNTech Shows Promise

Updated Category News Views 244

Revamped Approach to COVID-19 Vaccination In a noteworthy advancement in the fight against the COVID-19 pandemic, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) are set to introduce an LP.8.1-adapted monovalent COVID-19 vaccine following a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)....

Continue Reading
Gold's Steady Climb Amid Geopolitical Tensions and Economic Shifts

Updated Category News Views 210

Gold Rises for Third Consecutive Session Gold (XAU/USD) has shown a steady increase of over 0.32%, reflecting a notable rise in safe-haven demand driven by global trade tensions. Investors remain concerned about the stability of global supply chains, making gold a popular choice during times of uncertainty. The yellow metal typically shines as a safe-haven asset when...

Continue Reading